Clinical Trial Services

Finding New Efficiencies in Clinical Trial Logistics

June 01, 2020

BioPharm International

The COVID-19 pandemic has led to increased demand for direct-to-patient shipments, challenging cold-chain specialists to become more agile and to strengthen their global distribution networks.

2019 Investments Centered around Cell and Gene Therapies

June 01, 2020

BioPharm International

Previous investments set a foundation for later efficiency improvements.

What’s Next in Air Transportation

June 01, 2020

BioPharm International

The future will bring changes for temperature-controlled container rental companies.

Eli Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic

March 25, 2020

The company announced the status of new and ongoing clinical trial activities during the COVID-19 pandemic.

FDA Updates Clinical Research Policy to Reflect COVID-19 Disruptions

March 20, 2020

FDA is offering advice and added flexibility to help sponsors adjust ongoing and planned clinical research programs during the COVID-19 outbreak.

FDA Issues Guidance for Conducting Clinical Trials During COVID-19 Outbreak

March 19, 2020

The guidance details considerations FDA has set in place to assure the safety of participants while maintaining compliance with good clinical practices and minimizing risks to trial integrity.

Catalent Launches Direct-to-Patient Clinical Supply Services

January 15, 2020

Catalent’s FlexDirect service offers sponsors multiple delivery options from a single inventory.

NIH Launches Clinical Trial that Compares Stem Cell Transplantation to Biologic Therapies for MS Treatment

January 10, 2020

The trial will test experimental stem-cell treatments against biologic therapies for severe forms of relapsing multiple sclerosis.

Catalent Announces Clinical Trial Planning Service

January 03, 2020

Catalent’s planning service is designed to assist in evaluating needs for launching and maintaining clinical trials.

Sangamo Gains MHRA Authorization for Clinical Trial of CAR-Treg Therapy

November 21, 2019

Sangamo Therapeutics has revealed that the United Kingdom’s Medicines Healthcare Products Regulatory Agency (MHRA) has authorized the first in-human clinical trial evaluating a chimeric antigen receptor regulatory T cell (CAR-Treg) therapy.